TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $23

Benzinga · 3d ago
TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $19 to $23.